I am an executive biotechnology leader with over 20 years of international experience building and scaling innovation-driven businesses across pharmaceuticals, industrial biotech, and food ingredients. Most recently, I served as Chief Scientific Officer, leading a global R&D and regulatory organization and delivering a €100M+ innovation pipeline focused on next-generation manufacturing platforms and sustainable growth. My work sits at the intersection of science, industrialization, and business strategy. I specialize in translating complex scientific capabilities—such as fermentation, enzymatic technologies, and biocatalysis—into scalable industrial processes and commercially viable platforms. This includes defining innovation strategies, building and governing R&D portfolios, and guiding technologies from early development through scale-up and market implementation. I partner with CEOs, executive teams, and investors to address questions such as where to play in biotech, how to build competitive capabilities, and how to turn scientific innovation into measurable business impact. My experience spans global organizations and transformation environments, where aligning R&D, operations, and commercial priorities is critical to success. Areas of focus include biotech strategy and platform development, innovation pipeline creation, industrialization and scale-up, and make/buy/partner decisions across complex ecosystems.